4D Molecular Therapeutics FDMT
NASDAQ FDMT
$14.22 -0.10 (-0.66%)
As of: Oct 1, 2026 · 11:55 AM EDT

4D Molecular Therapeutics (FDMT) Cash from Financing Activities (2020 - 2026)

Updated

4D Molecular Therapeutics (FDMT) posted Cash from Financing Activities of $42.34 million for Q2 2026, compared with $862,000 a year earlier and up 268.7% from the prior quarter.

Analysis

4D Molecular Therapeutics (FDMT) Cash from Financing Activities (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Cash from Financing Activities at 4D Molecular Therapeutics was $165.92 million; for FY2025, it came in at $112.96 million, down 66.5% from FY2024.

  • Annual Cash from Financing Activities shows a five-year compound annual growth rate of -16.5% (FY2020 to FY2025).
  • In prior years, 4D Molecular Therapeutics' Cash from Financing Activities was $337.25 million in FY2024 (+115.0%), $156.83 million in FY2023, $3.09 million in FY2022 (-97.4%) and $118.09 million in FY2021 (-57.7%).
  • Quarterly Cash from Financing Activities has run from a low of -$50,000 in Q2 2022 to a high of $318.83 million in Q1 2024 over five years.
  • The strongest year-over-year quarter for Cash from Financing Activities in the past five years was Q4 2023, with growth of 132.7%; the weakest was Q4 2022, with a decline of 98.2%.
  • According to Business Quant data, Cash from Financing Activities for the three prior quarters was $11.48 million (Q1 2026), $111.98 million (Q4 2025) and $116,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 4D Molecular Therapeutics 1.01 Bn -454.35 Mn - 42.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 42.34 Mn
Mar 31, 2026 11.48 Mn
Dec 31, 2025 111.98 Mn
Sep 30, 2025 116,000.00
Jun 30, 2025 862,000.00
Dec 31, 2024 601,000.00
Sep 30, 2024 568,000.00
Jun 30, 2024 17.25 Mn
Mar 31, 2024 318.83 Mn
Dec 31, 2023 4.76 Mn
Sep 30, 2023 10.56 Mn
Jun 30, 2023 130.52 Mn
Mar 31, 2023 10.99 Mn
Dec 31, 2022 2.05 Mn
Sep 30, 2022 460,000.00
Jun 30, 2022 -50,000.00
Mar 31, 2022 629,000.00
Dec 31, 2021 116.14 Mn
Sep 30, 2021 1.98 Mn
Jun 30, 2021 820,000.00
API Access

4D Molecular Therapeutics Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=FDMT&period=max&api_key=YOUR_API_KEY